717 results on '"Ollila, David W"'
Search Results
2. ASO Visual Abstract: Nodal Response and Survival After Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive Breast Cancer: 20-Year Experience from a Single Institution
3. Does Preoperative MRI Reduce Positive Margins after Breast-Conserving Surgery?
4. Disease-Associated Risk Variants in ANRIL Are Associated with Tumor-Infiltrating Lymphocyte Presence in Primary Melanomas in the Population-Based GEM Study
5. Comparison of community pathologists with expert dermatopathologists evaluating Breslow thickness and histopathologic subtype in a large international population-based study of melanoma
6. Association of Melanoma-Risk Variants with Primary Melanoma Tumor Prognostic Characteristics and Melanoma-Specific Survival in the GEM Study
7. ASO Visual Abstract: Does Preoperative MRI Reduce Positive Margins After Breast Conserving Surgery?
8. Phase II Single-Arm Study of Preoperative Letrozole for Estrogen Receptor-Positive Postmenopausal Ductal Carcinoma In Situ: CALGB 40903 (Alliance).
9. Sociodemographic and Clinical Predictors of Neoadjuvant Chemotherapy in cT1-T2/N0 HER2-Amplified Breast Cancer
10. Inherited Genetic Variants Associated with Melanoma BRAF/NRAS Subtypes
11. International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node-Positive Melanoma at Major Referral Centers
12. Characterization of the CpG Island Hypermethylated Phenotype Subclass in Primary Melanomas
13. Talimogene Laherparepvec (T-VEC) for the Treatment of Advanced Locoregional Melanoma After Failure of Immunotherapy: An International Multi-Institutional Experience
14. Pathologic complete response and survival after neoadjuvant chemotherapy in cT1-T2/N0 HER2+ breast cancer
15. The impact of age and nodal status on variations in oncotype DX testing and adjuvant treatment
16. The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanoma
17. The Role of PET/CT in Melanoma Patients: A Surgeon’s Perspective
18. Associations of MC1R Genotype and Patient Phenotypes with BRAF and NRAS Mutations in Melanoma
19. Factors Associated with Nodal Pathologic Complete Response Among Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Results of CALGB 40601 (HER2+) and 40603 (Triple-Negative) (Alliance)
20. Gender Bias in Surgical Oncology Fellowship Recommendation Letters: Gaining Progress
21. Impact of Cavity Shave Margins on Margin Status in Patients with Pure Ductal Carcinoma In Situ
22. Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis
23. The Role of Intraoperative Radiation in Early-stage Breast Cancer
24. Association of Incident Amelanotic Melanoma With Phenotypic Characteristics, MC1R Status, and Prior Amelanotic Melanoma
25. The Difficult Reality of Active Surveillance and the Urgent Need for Ongoing Research
26. Use and Costs of Sentinel Lymph Node Biopsy in Non-Ulcerated T1b Melanoma: Analysis of a Population-Based Registry
27. Characterization of Sentinel Lymph Node Immune Signatures and Implications for Risk Stratification for Adjuvant Therapy in Melanoma
28. Surgical Options in Management of the Breast and Axilla: Independent Choices?
29. Ultrasound-guided Intralesional Injection of Talimogene laherparepvec (Imlygic) for Advanced Melanoma: Technical Note on a Preliminary Experience
30. Direct Comparison of In-Person Versus Virtual Interviews for Complex General Surgical Oncology Fellowship in the COVID-19 Era
31. The Prognostic Value of Axillary Staging Following Neoadjuvant Chemotherapy in Inflammatory Breast Cancer
32. MRI-guided core needle biopsy of the breast: Radiology-pathology correlation and impact on clinical management
33. Use of Completion Lymph Node Dissection for Sentinel Lymph Node-Positive Melanoma
34. Association of Interferon Regulatory Factor-4 Polymorphism rs12203592 With Divergent Melanoma Pathways
35. ASO Visual Abstract: Sociodemographic and Clinical Predictors of Neoadjuvant Chemotherapy in cT1-T2/N0 HER2-Amplified Breast Cancer
36. Trends in Surgical Axillary Management in Early Stage Breast Cancer in Elderly Women: Continued Over-Treatment
37. Inherited Genetic Variants Associated with Occurrence of Multiple Primary Melanoma
38. Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma
39. Surgery for Stage IV Metastatic Melanoma
40. ASO Visual Abstract: Talimogene Laherparepvec (T-VEC) for Treatment of Advanced Locoregional Melanoma after Failure of Immunotherapy: An International Multi-institutional Experience
41. Comparison of Clinicopathologic Features and Survival of Histopathologically Amelanotic and Pigmented Melanomas: A Population-Based Study
42. Indications for Neoadjuvant Systemic Therapy for Breast Cancer
43. Identification of a Robust Methylation Classifier for Cutaneous Melanoma Diagnosis
44. Real-World Outcomes of Talimogene Laherparepvec Therapy: A Multi-Institutional Experience
45. The Role of PET/CT in Melanoma Patients: A Surgeon’s Perspective
46. Local Recurrence Rates are Low in High-Risk Neoadjuvant Breast Cancer in the I-SPY 1 Trial (CALGB 150007/150012; ACRIN 6657)
47. Inherited Genetic Variants Associated with Melanoma BRAF/NRAS Subtypes
48. ASO Visual Abstract: Factors Associated with Nodal Pathologic Complete Response Among Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Results of CALGB 40601 (HER2+) and 40603 (Triple-Negative) (Alliance)
49. Clinical and Histological Response to Talimogene Laherparepvec Therapy in Advanced Melanoma: Impact on Overall Survival.
50. Lymph node metastases in young patients with gastrointestinal stromal tumor: A nationwide analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.